Found 69 matching trials
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
PHASE1This pilot clinical trial studies the side effects and best dose of ruxolit...
Location
City of Hope Medical Center
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years
PHASE2Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Location
Saint Louis hospital
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
PHASE2The researchers are doing this study to compare 2 different GVHD prevention...
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
PHASE2Cord blood (CB) transplants are an option for patients lacking an HLA ident...
Location
University of Colorado School of Medicine. Anschutz Medical Campus
Abatacept as GVHD Prophylaxis Phase 2
PHASE2This is a phase II multi-center, randomized, double blind, placebo-controll...
Location
Children's Hospital Los Angeles
Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia
PHASE1This is a Phase 1 clinical study designed to evaluate the safety, tolerabil...
Location
Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital
Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
PHASE2To determine whether treatment with ustekinumab will alter the ratio of T R...
Location
H. Lee Moffitt Cancer Center & Research Institute
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer
PHASE1Men with progressive metastatic Castration-Resistant Prostate Cancer post f...
Location
Johns Hopkins Hospital
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
PHASE1RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Location
Massachusetts General Hospital
Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
PHASE3This randomized clinical trial will evaluate two approaches of GvHD prophyl...
Location
King Faisal Specialist Hospital & Research Center